
Beyond the bin: Rethinking bioplastic waste for a circular future
Bioplastics are made from renewable sources, which sounds ideal, but some are compostable or biodegradable only under certain conditions. Now Stellenbosch University has found that enzymes may be the solution.. Photo: Sustainable Seas Trust
Plastic is everywhere. From packaging our food to building our homes and medical equipment, we've come to rely on it for nearly everything. But our dependence on plastic has come at a cost that the environment can no longer bear.
We now know that plastic pollution is choking our oceans, polluting soils, harming wildlife, and posing a threat to human health. That's why this
One solution that has garnered considerable attention is bioplastics. These materials resemble regular plastics in appearance and function but are made from renewable sources, such as corn or sugarcane, and often are certified as biodegradable or compostable. It sounds like a dream: plastic without the pollution.
But the reality is more complicated. Not all bioplastics are created equal. Some are biodegradable, meaning they can break down naturally, but only under specific conditions. Others are compostable, but only in large-scale industrial composting facilities, not your backyard compost heap. Still others are bio-based versions of conventional plastics and don't degrade at all.
Another key issue is that evidence suggests certifications are not aligned with real-world outcomes. Authorities are now addressing this through a review process, specifically to bring the EN13432 compostable certification — a European standard that defines the requirements for packaging recoverable through composting and biodegradation — closer in line with real-world end-of-life scenarios. The bottom line? These materials are often misunderstood by consumers, companies and even governments.
Many people assume that tossing a bioplastic item into nature or a regular bin is fine, but without the right conditions, most of these materials don't degrade within the timeframes for which they were certified. Even worse, if they're sent to waste management facilities already processing other waste streams, such as PET recycling facilities that handle polyethylene terephthalate — a strong and durable plastic — they can disrupt and jeopardise these processes.
Above all, when bioplastics are mismanaged, we lose valuable carbon that could have been recovered and reused, thereby undermining the very purpose for which these materials were created.
The truth is that our waste systems are not designed to handle bioplastics, at least not now and not at scale.
Take Italy, for example. The country has made significant progress in encouraging the use of bioplastics, even mandating their use for shopping bags, takeaway containers and the collection of organic waste. These bioplastics are legally required to be sent to organic waste management facilities, such as composters and anaerobic digestion plants.
Despite good intentions, much of the bioplastic-containing waste is pulled out at the start of the treatment process, along with other large or 'unusual' items, and sent to incineration instead. Why? Because old treatment plants weren't designed to handle large quantities of bioplastics. This leads the facilities to believe that the risk of disrupting their processes is just too high to treat bioplastics properly.
The problem isn't with bioplastics themselves; they can and should be a big part of the portfolio of solutions to combat plastic pollution. It's that existing waste management systems weren't built around them. Moreover, in the developing world, most cities lack proper industrial composting or anaerobic digestion facilities. There's little public awareness on how to dispose of bioplastics correctly. And our recycling technologies haven't caught up with the complexity of these new materials. As a result, the promise of bioplastics is falling short. But it doesn't have to be this way.
At
This means that less bioplastic waste is sent to landfills or incinerators, but also that we get as much value as possible from bioplastic materials before they are composted. It's a system designed not just to clean up plastic, but to recapture carbon — the most valuable currency in the world — and keep it cycling in the economy where it belongs.
Of course, new technologies are only part of the solution. Public education is just as important. Most people still don't understand the difference between biodegradable and compostable, or how to identify a bioplastic in the first place. Clear labelling, public awareness, consistent regulations and accessible disposal systems are essential. It's also time for governments to step up.
There is a need for investment in composting and recycling infrastructure, as well as extended producer responsibility laws that hold companies accountable for the waste their products generate. Additionally, incentives are necessary to encourage better product design and effective product management after use.
Crucially, we must be honest about where bioplastics make the most sense. They're great for short-lived, disposable items, such as food packaging or compostable liners, where collection and treatment can be controlled. But they're not a blanket replacement for all plastic. In some cases, reusable options or better recycling systems offer more environmental benefits.
Bioplastics won't fix our waste crisis overnight. They're not a silver bullet. But, with innovative design, responsible production, as well as proper disposal and waste management systems, they can be part of a much-needed shift toward circular, sustainable materials. And that's the future we need. One where resources aren't wasted, ecosystems aren't harmed, and people, businesses and governments work together to protect the only home we have.
Consumers, too, have a role to play. Start by reading labels carefully. If something is labelled 'compostable,' it usually means it needs the high heat and controlled conditions of an industrial composting facility — not your backyard bin.
So, compost carefully, and where possible, check if your local waste system accepts compostable plastics. If not, advocate for better infrastructure. Try to reduce single-use items altogether and support companies developing genuinely sustainable alternatives.
Every action counts. When we work together, scientists, citizens, companies and cities, we can shape a future where waste is not just managed but transformed into a resource.
Dominique Rocher is a co-tutelage PhD researcher at Stellenbosch University (SU) and the University of Padova. Dr Wessel Myburgh is a post-doctoral researcher at SU and the University of Padova. They are co-founders of Urobo Biotech, a waste-to-value spinout focused on enzymatic solutions for bioplastic-rich waste streams
.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

The Herald
14 hours ago
- The Herald
South Africa to ramp up vaccinations as foot-and-mouth disease spreads
South Africa is building up vaccine stocks and expanding inoculations to fight a worsening foot-and-mouth disease (FMD) outbreak, the agriculture ministry said, as the country faces threats to beef supplies. FMD is a highly contagious viral infection of cloven-hoofed animals that may also affect other species. Flare-ups have been reported over the past several months in five provinces, with KwaZulu-Natal being the worst affected. This week Karan Beef, which operates the country's largest feedlot and one of the world's biggest, reported an outbreak at its facility in Heidelberg, about 50km southeast of Johannesburg. The quarantine imposed on the feedlot, which slaughters about 2,000 cattle daily, could affect beef supplies. The government has ordered more than 900,000 doses of FMD vaccines, with the first batch expected to arrive next week, the ministry said on Thursday. 'These plans are not only about responding to outbreaks but also about building permanent infrastructure to manage future risks,' it said.

The Herald
20 hours ago
- The Herald
First-ever mass vaccination of poultry in SA to combat bird flu
Agriculture minister John Steenhuisen on Thursday announced the first mass vaccination of poultry in the country to protect the local flock from avian flu. He also announced that the department had also ordered vaccines to combat foot and mouth disease. 'Our vaccination team, comprising poultry specialist vets from the University of Pretoria, along with the Agricultural Research Council, has received a list of farms to be vaccinated from the poultry industry and is prioritising high-risk areas and commercial flocks to contain the virus and prevent further culling,' Steenhuisen said. He said the country had secured a vaccine supply, ensured cold chain capacity and was building traceability and reporting mechanisms as part of a wider preparedness strategy . In addition, 50 animal health technicians were appointed on short-term contracts to help with the vaccination rollout. Their induction and refresher training was expected to start next week. Steenhuisen said the department had also ordered foot and mouth disease vaccines to cover KwaZulu-Natal, while assessment, as well forward and backward tracing of the outbreak in Gauteng, was ongoing. More than 900,000 doses of vaccines were ordered and the first batch is expected to arrive next week. 'These plans are not only about responding to outbreaks, but also about building permanent infrastructure to manage future risks. 'More broadly, we are establishing a biosecurity council that will bring together the police, veterinarians, scientists, the Border Management Authority and industry. We are rolling out a farm-to-fork national traceability system for livestock,' Steenhuisen said. He said Onderstepoort was being upgraded to restore vaccine self-sufficiency and rural veterinary services and emergency response were enhanced. The dip-tank model in partnership with traditional leaders was also being introduced. Steenhuisen praised Karan Beef for its quick response to the foot and mouth outbreak in its Heidelberg facility d uring a virtual meeting on Wednesday night with the company and departmental officials. The agriculture department said there were still signs of active virus circulation in the disease management area (DMA) in KwaZulu-Natal, with some outbreaks detected outside the DMA. A system has been put in place to assess the level of biosecurity on individual farms, with the intention of aligning the control measures to the biosecurity risks. TimesLIVE


Mail & Guardian
a day ago
- Mail & Guardian
NGOs count the cost of lost United States funding
No service: The US government's funding cuts have put further strain on already overloaded clinics and forced some to close their doors. (Delwyn Verasamy) South Africa's non-profit organisations are still counting the costs of the cessation of US funding earlier this year, with financial shortfalls leading to healthcare job losses while critical HIV vaccine services and research have been heavily scaled back. US President Donald Trump announced in January that he was cutting US Agency for International Development ( According to official data, USAid disbursed $24.5 billion to organisations in the 2024 financial year. Accountability Lab, a global network for transparency and open government, ran a survey of 266 organisations affected by the freeze from 1 to 18 May, and a third reported being 'at imminent risk of closure', with African countries — Kenya, Nigeria, the Democratic Republic of the Congo, Uganda and Ghana — the most affected. 'Nine of the top 10 most affected are African countries, with El Salvador rounding out the top 10. Others include South Africa, Cameroon, Senegal and the US,' said Accountability Lab's global communications director Sheena Adams. 'Worryingly, 21% have only one month of financial resources remaining, while 24% report a three-month financial runway. 'In terms of job losses, almost 55% of respondents reported having furloughed or laid off staff, with a further 14% confirming that layoffs were under consideration. According to the state department, the US government committed $330 million in aid to South Africa last year, with $318.2 million coming from USAid. The lion's share, $219.7 million, was for HIV/Aids, followed by $43.11 million for basic health, $31.8 million for operating expenses, $7.512 million to environmental protection, $7.006 million for trade policy and regulation, $3.677 million for agriculture, $3.512 million for government and civil society and $1.608 million to basic education. The aid suspension will roll back progress in the fight against HIV/Aids, says activist group Treatment Action Campaign (TAC). 'The USAid and Pepfar [the US President's Emergency Plan for AIDS Relief] funding freeze has had a chilling effect on the global fight against HIV/Aids, particularly in countries like South Africa that bear a high burden of disease,' TAC spokesperson Xabisa Qwabe said. 'Many community-led organisations — including treatment literacy programmes, support groups and outreach initiatives — have had to scale down or suspend operations. 'Pepfar funding [disbursed by TAC received substantial support from USAid/Pepfar through the Ritshidze Project, which enabled it to monitor service delivery, engage communities and hold the health system accountable. 'At its peak, up to 60% or more of TAC's operational budget was supported through this funding stream,' Qwabe said, adding that dozens of jobs had been lost. 'Staff retrenchments have occurred, particularly among community health educators and coordinators working in high-burden districts. The exact number may vary by province, but it has affected dozens of livelihoods. 'TAC's presence in many communities has been scaled back, meaning fewer workshops on treatment literacy, weaker monitoring of medicine stockouts and reduced mobilisation for treatment access and rights-based advocacy.' Pepfar funding didn't directly pay for medication in South Africa but funded crucial support systems. 'The funding freeze has disrupted these support structures, leading to reduced testing, longer turnaround times and greater strain on overburdened clinics. Patients are increasingly falling through the cracks, especially in under-resourced communities,' she said. TAC is actively seeking alternative funding, including local philanthropic partners, international donors, and development agencies, and has urged the government to step up support for civil society organisations. 'While some government departments have expressed willingness to explore support avenues, this is yet to materialise in substantial funding,' Qwabe added. The solution, she said, is the urgent resumption of Pepfar funding with clear transition plans. 'We also need a stronger financial commitment from the South African government to support community-led health programmes. There should be greater investment in building sustainable, locally owned health infrastructure that doesn't rely solely on foreign aid. Civil society must be recognised as a vital partner in achieving these goals. 'This funding crisis is not just a bureaucratic issue — it's a humanitarian emergency. 'Patients are losing access to services and dedicated community health workers are losing jobs they've held for years. These are the very people who ensured South Africa's HIV treatment scale-up succeeded.' 'We're beginning to hear reports that HIV testing is not being done as much as it was before, viral load testing and CD4 count testing is coming down, which obviously will have an impact on our ability to keep people virally suppressed. 'People will get sicker, and once they are no longer virally suppressed, they are also at risk of transmitting the virus,' Gray warned. 'We will probably see both an increase in morbidity and, if we're not careful, mortality in both children and adults who are not properly in care.' She noted that USAid and National Institute of Health (NIH) funding had supported scientific trials, adding: 'This has huge effects on HIV science and TB science, because we were involved in everything from vaccine research and development in both HIV and TB, as well as HIV cure, TB treatment trials and HIV treatment trials.' 'It also affects the NIH funding that supported clinical trial research infrastructure, laboratory research infrastructure and the whole ecosystem required to do innovation in HIV and TB — from discovery to pre-clinical testing to clinical trials to biomarker discovery. 'That whole ecosystem of innovation is severely hampered. The NIH funding was substantial — up to $250 million per annum.' There have been job losses affecting a range of people involved in the work, from scientists and master's students to nurses and drivers. 'It has a huge impact on the human resources for research. That has an effect both at a macro and micro level on the economy. Drivers, counsellors, recruiters — all of them get retrenched, which means their families are thrown into poverty. 'If you have a quarter of a million US dollars of revenue coming in, all of that gets taxed, so there's also an impact on revenue collection.' For example, the Perinatal HIV Research Unit at Baragwanath Hospital in Johannesburg has retrenched 70 staff members after losing NIH funding, which comprised 66% of its income. 'A lot more people will be retrenched over the next couple of months as the money dries up. 'Unless the research unit is able to diversify its funding stream it faces even further closure,' Gray said. The loss of its USAid funding also forced the Brilliant Consortium to hal 'The vaccine manufacturing has been put on hold but we managed to find funding [from the Gates Foundation] to conduct a smaller study at a single site in South Africa,' Gray said. The 'Many of our partners have completely shut down programmes and had to retrench staff and we are already feeling that we have to fill some of those gaps. 'Even testing kids the other day, we were down to one … how can you turn someone away from knowing their status? In the community there are concerns about whether people will be able to get their medication for their children,' she said. 'As a community-based organisation that has been serving our local community for 35 years, it's just heartbreaking to see the ripple effects of what has progressed. 'It's those who don't have options who are going to suffer the most. 'It is tragic. HIV has always been a global initiative with global targets and countries working together as a global community — and that has been destroyed.'